Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 3.40B | 3.51B | 4.42B | 4.28B | 2.79B |
Gross Profit | 647.60M | 716.50M | 1.13B | 1.03B | 496.70M |
EBITDA | 360.00M | 511.90M | 831.70M | 695.20M | 281.60M |
Net Income | 219.60M | 349.00M | 643.60M | 555.50M | 217.00M |
Balance Sheet | |||||
Total Assets | 6.29B | 6.25B | 6.48B | 6.24B | 5.75B |
Cash, Cash Equivalents and Short-Term Investments | 647.40M | 764.90M | 952.30M | 921.00M | 823.00M |
Total Debt | 121.00M | 126.80M | 115.50M | 111.40M | 131.60M |
Total Liabilities | 1.89B | 1.73B | 1.98B | 1.93B | 1.73B |
Stockholders Equity | 4.41B | 4.52B | 4.50B | 4.31B | 4.02B |
Cash Flow | |||||
Free Cash Flow | 189.60M | 122.70M | 475.40M | 427.30M | -309.20M |
Operating Cash Flow | 193.00M | 129.60M | 477.50M | 431.90M | -301.20M |
Investing Cash Flow | 45.80M | 27.40M | 33.60M | -10.30M | -23.90M |
Financing Cash Flow | -352.30M | -342.80M | -482.40M | -321.70M | 516.40M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | £3.51B | 9.65 | 10.73% | 183.95% | 0.39% | -17.64% | |
71 Outperform | £2.00B | 0.29 | 2.27% | ― | 6.04% | -66.96% | |
71 Outperform | £3.83B | 14.32 | 7.71% | 662.52% | 15.42% | 4.45% | |
70 Outperform | £3.96B | 18.02 | 4.92% | 611.79% | -3.22% | -37.21% | |
64 Neutral | £3.12B | 21.24 | 4.22% | 116.77% | -11.63% | -31.81% | |
60 Neutral | £5.97B | 40.00 | 1.81% | 262.91% | 4.78% | -53.59% | |
56 Neutral | HK$24.58B | 3.79 | -2.03% | 6.58% | -0.32% | -67.68% |